Truion News
Stay up to date – Truion news
Here you will find all the latest information about Truion and our mission to enable the early detection of CatSper-related infertility worldwide. Stay informed about our latest developments and follow us on LinkedIn to never miss an update.
🧬 Spermatology 2026 in Birmingham
We had the pleasure of sponsoring the XV International Symposium on Spermatology, hosted by the University of Birmingham and the Centre for Human Reproductive Science (ChRS). It was a privilege to be part of this unique community of researchers from around the world,...
🇬🇧 ESHRE 2026 – An Incredible Week in London
The Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) was filled with inspiring conversations, innovative ideas, and valuable new connections.🔬 We were especially excited to see CatFlux highlighted during the main sessions as a prime...
🎉 The patent in Europe is granted
This is a major milestone for Truion. The grant of our European patent reflects years of scientific work, development, and validation. It is also an important recognition of the innovation behind our technology. At the same time, it strengthens Truion’s development...
Clinical tour in Bucharest, Romania
Over the past three and a half days, we had the opportunity to introduce CatSper, CatSper-related infertility, and the CatSperTest with CatFlux to seven clinics. It was an incredibly valuable experience to better understand the specific needs of the Romanian market...
🚀 Truion & Nexpring Expand Collaboration In Europe
We are proud to announce the extension of our collaboration with Nexpring Health — the new polar star in the IVF market, known for its scientific excellence, and commitment to continuous innovation in reproductive medicine. Together with Nexpring Health, we are...
MEFS 2025 – Truion again in the Middle East.
The the Middle Eastern Fertility Society (MEFS) in Dubai was filled with inspiring conversations, cutting-edge ideas, and valuable connections. Together with our partner Health Gateway, we are sharing insights on CatSper, CatSper-related infertility, and how CatFlux...
Big news! 🎉 Truion GmbH has officially received its ISO 13485:2016 certification from DEKRA! ✅
This internationally recognized standard confirms that our quality management system meets the highest requirements for safety, reliability, and regulatory compliance in medical devices. For us at Truion, this milestone is more than a certification — it’s a...
🇫🇷 ESHRE 2025 – An Incredible Week in Paris 🗼
The Congress of European Society of Human Reproduction and Embryology was filled with inspiring conversations, cutting-edge ideas, and valuable connections. A heartfelt thank-you to everyone who stopped by our booth and showed interest in CatFlux, our innovative...
🌐 Investor Days Thüringen – Truion in the international spotlight!
We’re thrilled to have taken the stage to present Truion on June 4th and 5th 2025, at the Investor Days Thüringen — hosted in the historic Peterskirche — where we joined forces with entrepreneurs from South Africa, the Netherlands, Belgium, Spain, and Germany to...
🇸🇬 Truion at ASPIRE 2025 – Singapore
We’re proud to be part of ASPIRE2025 in Singapore, where global experts come together to explore the latest advances in reproductive medicine. It’s inspiring to see worldwide interest in CatSper’s role in fertilization and the need to inform patients about...